Skip to main content
logo
Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0150
+0.0006 (4.17%)
Aug 1, 2025, 2:10 PM EDT

Chimerix Revenue

Emmaus Life Sciences had revenue of $2.41M in the quarter ending March 31, 2025, a decrease of -3.99%. This brings the company's revenue in the last twelve months to $16.55M, down -34.70% year-over-year. In the year 2024, Emmaus Life Sciences had annual revenue of $16.65M, down -43.73%.

Revenue (ttm)
16.55M
Revenue Growth
-34.70%
P/S Ratio
0.06
Revenue / Employee
472.94K
Employees
35
Market Cap
957.98K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.65M-12.94M-43.73%
Dec 31, 202329.60M11.21M60.94%
Dec 31, 202218.39M-2.22M-10.77%
Dec 31, 202120.61M-2.56M-11.04%
Dec 31, 202023.17M415.00K1.82%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Endo, Inc.1.73B
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
Silence Therapeutics27.70M
Revenue Rankings

Emmaus Life Sciences News

More News